Cargando…
Did animal offer relevant model for Bevacizumab testing?
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579700/ https://www.ncbi.nlm.nih.gov/pubmed/18971937 http://dx.doi.org/10.1038/sj.bjc.6604693 |
| _version_ | 1782160587814338560 |
|---|---|
| author | Eveno, C Gaujoux, S Tobelem, G Pocard, M |
| author_facet | Eveno, C Gaujoux, S Tobelem, G Pocard, M |
| author_sort | Eveno, C |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2579700 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2008 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-25797002009-11-04 Did animal offer relevant model for Bevacizumab testing? Eveno, C Gaujoux, S Tobelem, G Pocard, M Br J Cancer Letter to the Editor Nature Publishing Group 2008-11-04 2008-10-07 /pmc/articles/PMC2579700/ /pubmed/18971937 http://dx.doi.org/10.1038/sj.bjc.6604693 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter to the Editor Eveno, C Gaujoux, S Tobelem, G Pocard, M Did animal offer relevant model for Bevacizumab testing? |
| title | Did animal offer relevant model for Bevacizumab testing? |
| title_full | Did animal offer relevant model for Bevacizumab testing? |
| title_fullStr | Did animal offer relevant model for Bevacizumab testing? |
| title_full_unstemmed | Did animal offer relevant model for Bevacizumab testing? |
| title_short | Did animal offer relevant model for Bevacizumab testing? |
| title_sort | did animal offer relevant model for bevacizumab testing? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579700/ https://www.ncbi.nlm.nih.gov/pubmed/18971937 http://dx.doi.org/10.1038/sj.bjc.6604693 |
| work_keys_str_mv | AT evenoc didanimalofferrelevantmodelforbevacizumabtesting AT gaujouxs didanimalofferrelevantmodelforbevacizumabtesting AT tobelemg didanimalofferrelevantmodelforbevacizumabtesting AT pocardm didanimalofferrelevantmodelforbevacizumabtesting |